Contract Packaging Predicted to See High Growth in 2024 Ahead of Pharmapack Europe
The new survey results are announced ahead of this month’s Pharmapack Europe 2024 (January 24/25th) – held at the Paris Expo, Porte de Versailles (Hall 7.2) – where more than 5000 attendees and 370 exhibitors are expected.
Global Pharma | 12/01/2024 | By Manvi | 421
Supriya Lifescience Attains Prestigious GMP Certification from ANVISA Brazil
This milestone is poised to expedite and streamline the registration process for the company’s remaining APIs, facilitating a smoother pathway for their introduction into the Brazilian market.
Global Pharma | 11/01/2024 | By Manvi | 672
Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
The agreement grants Radiance an option to license from Biocytogen a first-in-class fully human anti-HER2/TROP2 bispecific antibody-drug conjugate (BsADC) for therapeutic product development, manufacturing and commercialization for all human indications worldwide.
Global Pharma | 11/01/2024 | By Manvi | 658
AbbVie and Umoja Biopharma Announce Strategic Collaboration
AbbVie and Umoja Biopharma (Umoja), an early clinical-stage biotechnology company, have announced two exclusive option and license agreements to develop multiple in-situ generated CAR-T cell therapy candidates in oncology using Umoja's proprietary VivoVec platform.
Global Pharma | 11/01/2024 | By Manvi | 781
Hikal Commits INR 500 Cr Investment in Panoli Plant, Signs MoU with Gujarat Government
According to the terms of the MoU, Hikal will make a substantial investment of INR 500 crores into the existing fine chemical plant located at Panoli, Gujarat.
Global Pharma | 10/01/2024 | By Manvi | 1452
Gujarat's Holistic Healthcare Summit Sets Stage for Vibrant Gujarat Global Summit
Gujarat has established a comprehensive healthcare ecosystem, spanning government, private, corporate, and public-private partnership (PPP) models.
Global Pharma | 10/01/2024 | By Manvi | 508
Union Health Minister Inaugurates Multiple Healthcare Facilities in New Delhi
The Union Health Minister highlighted the changing dynamics of the health sector in India.
Global Pharma | 09/01/2024 | By Manvi | 465
Cipla Announces JV in US with Kemwell Biopharma and Manipal Education & Medical Group
The primary goal of this joint venture is to develop and commercialise novel Cell therapy products for major unmet medical needs in the United States, Japan, and EU regions.
Global Pharma | 09/01/2024 | By Manvi | 587
MOMA Therapeutics and Roche Announce Five-Year Discovery Collaboration
This partnership provides Roche with access to MOMA’s proprietary KnowledgeBase platform for the identification and prosecution of a certain number of novel drug targets involved in promoting cancer cell growth and survival.
Global Pharma | 09/01/2024 | By Manvi | 526
Novartis Set to Acquire Calypso in Transformative Agreement
Calypso, a spin-out from Merck, is focused on the research and development of monoclonal antibodies for an array of autoimmune indications, with an expertise in IL-15 biology.
Global Pharma | 08/01/2024 | By Manvi | 648
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy